The Hallmarks of Precancer
Overview
Authors
Affiliations
Research on precancers, as defined as at-risk tissues and early lesions, is of high significance given the effectiveness of early intervention. We discuss the need for risk stratification to prevent overtreatment, an emphasis on the role of genetic and epigenetic aging when considering risk, and the importance of integrating macroenvironmental risk factors with molecules and cells in lesions and at-risk normal tissues for developing effective intervention and health policy strategies.
Haploinsufficient phenotypes promote selection of PTEN and ARID1A-deficient clones in human colon.
Skoufou-Papoutsaki N, Adler S, Mehmed S, Tume C, Olpe C, Morrissey E EMBO Rep. 2025; 26(5):1269-1289.
PMID: 39920335 PMC: 11893880. DOI: 10.1038/s44319-025-00373-0.
Insights to aging prediction with AI based epigenetic clocks.
Levy J, Diallo A, Saldias Montivero M, Gabbita S, Salas L, Christensen B Epigenomics. 2024; 17(1):49-57.
PMID: 39584810 PMC: 11703013. DOI: 10.1080/17501911.2024.2432854.
He J, Perera D, Wen W, Ping J, Li Q, Lyu L Nucleic Acids Res. 2024; 53(1).
PMID: 39535029 PMC: 11724290. DOI: 10.1093/nar/gkae1035.
Emerging strategies to investigate the biology of early cancer.
Zhou R, Tang X, Wang Y Nat Rev Cancer. 2024; 24(12):850-866.
PMID: 39433978 DOI: 10.1038/s41568-024-00754-y.
Kader T, Lin J, Hug C, Coy S, Chen Y, de Bruijn I bioRxiv. 2024; .
PMID: 39386723 PMC: 11463462. DOI: 10.1101/2024.09.25.615007.